Assessing Ovarian Function During Prolonged Implant Use
Sponsor: Merck Sharp & Dohme LLC
A observational or N/A phase clinical study on Contraception, this trial is completed. The trial is conducted by Merck Sharp & Dohme LLC and has accumulated 12 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Sep 2022 — Jul 2024 [monthly]
Completed
Status: Recruiting → Completed
-
Jun 2022 — Sep 2022 [monthly]
Recruiting
▶ Show 7 earlier versions
-
Jan 2021 — Jun 2022 [monthly]
Recruiting
-
Sep 2020 — Jan 2021 [monthly]
Recruiting
-
Dec 2018 — Sep 2020 [monthly]
Recruiting
-
Jun 2018 — Dec 2018 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Feb 2018 — Apr 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
May 2017 — Feb 2018 [monthly]
Not Yet Recruiting NA
First recorded
Mar 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Merck Sharp & Dohme LLC
- Planned Parenthood of the St. Louis Region and Southwest Missouri
For direct contact, visit the study record on ClinicalTrials.gov .